Abstract
Histoplasma capsulatum is a common endemic mycosis. Infection typically goes unnoticed by an individual, but in immunosuppressed patients, it may become disseminated. We report a case of disseminated histoplasmosis occurring 6 weeks after a kidney transplant. We discuss disseminated histoplasmosis and review its characteristic clinical, laboratory, and histologic manifestations, as well as current treatment modalities.
MeSH terms
-
Amphotericin B / therapeutic use
-
Antifungal Agents / therapeutic use
-
Bone Marrow / microbiology
-
Dermatomycoses / diagnosis*
-
Dermatomycoses / drug therapy
-
Dermatomycoses / microbiology
-
Histoplasmosis / diagnosis*
-
Histoplasmosis / drug therapy
-
Humans
-
Immunocompromised Host
-
Kidney Transplantation / adverse effects*
-
Lung / microbiology
-
Male
-
Middle Aged
-
Pyrimidines / therapeutic use
-
Triazoles / therapeutic use
-
Voriconazole
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Amphotericin B
-
Voriconazole